Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS
Inflammation leads to atherosclerosis and acute coronary syndromes (ACS). We performed a prospective, observational study to assess association between the concentrations of inflammatory markers (high sensitivity C-reactive protein, hsCRP; high sensitivity interleukin6, hsIL-6; soluble CD40 ligand,...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2021-05-01
|
| Seri Bilgileri: | Platelets |
| Konular: | |
| Online Erişim: | http://dx.doi.org/10.1080/09537104.2020.1766670 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
